您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
黄海
黄海
所属职位: CEO
所属公司:

复星凯特生物科技有限公司

黄海先生2020年12月加入复星凯特生物科技有限公司担任CEO。公司立足于自主研发和技术转移相结合,致力于肿瘤免疫细胞治疗技术(CAR-T/TCR-T)在中国的产业化和规范化,造福中国患者。黄海先生在医药行业拥有近25年的丰富商业运营及国际化管理经验,曾先后在辉瑞、赛诺菲、罗氏诊断和美敦力等跨国药企任职。加入复星凯特前,担任辉瑞普强首席运营官(COO),曾在2018年打造了中国首个年销售额达12亿美元的单产品;并在带量采购的大环境下,积极发展公司未来战略,布局互联网医疗。Mr. Huang Hai joined Fosun Kite Biotechnology Co., Ltd. (FSK in short) as CEO in December 2020. Based on the combination of independent R&D and technology transfer, FSK is committed to the industrialization and standardization of tumor immune cell therapy technology (CAR-T/TCR-T) in China to benefit Chinese patients. Mr. Huang Hai has nearly 25 years of experience in commercial operations and international management in the pharmaceutical industry. He has worked in multinational pharmaceutical companies such as Pfizer, Sanofi, Roche Diagnostics and Medtronic. Prior to joining FSK, he served as the Chief Operating Officer (COO) of Upjohn China. In 2018, he created China’s first single product with annual sales of US$1.2 billion; and in the environment of mass procurement, he actively developed Upjohn’s future strategy and deployed Internet medical services. 

微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务